Related Experiment Video
Updated: Feb 27, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
Ciclopirox inhibits cancer cell proliferation by suppression of Cdc25A
Tao Shen1,2, Chaowei Shang1,2, Hongyu Zhou1
1Department of Biochemistry and Molecular Biology, Louisiana State University Health Sciences Center, Shreveport, LA, USA.
Abstract:
Ciclopirox olamine (CPX), an off-patent fungicide, has recently been identified as a novel anticancer agent. However, the molecular mechanism underlying its anticancer action remains to be elucidated. Here we show that CPX inhibits cell proliferation in part by downregulating the protein level of Cdc25A in tumor cells. Our studies revealed that CPX did not significantly reduce Cdc25A mRNA level or Cdc25A protein synthesis, but remarkably promoted Cdc25A protein degradation. This resulted in inhibition of G1-cyclin dependent kinases (CDKs), as evidenced by increased inhibitory phosphorylation of G1-CDKs. Since Cdc25A degradation is tightly related to its phosphorylation status, we further examined whether CPX alters Cdc25A phosphorylation. The results showed that CPX treatment increased the phosphorylation of Cdc25A (S76 and S82), but only Cdc25A-S82A mutant was resistant to CPX-induced degradation. Furthermore, ectopic expression of Cdc25A-S82A partially conferred resistance to CPX inhibition of cell proliferation. Therefore, our findings indicate that CPX inhibits cell proliferation at least in part by promoting Cdc25A degradation.
Insights
Ciclopirox olamine (CPX), an anticancer agent, inhibits tumor cell proliferation by promoting the degradation of Cdc25A protein. This mechanism involves increased phosphorylation of Cdc25A, leading to cell cycle arrest.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Ciclopirox olamine (CPX), an established fungicide, is a newly recognized anticancer agent.
- The precise molecular mechanisms driving CPX's anticancer effects require further investigation.
Purpose of the Study:
- To elucidate the molecular mechanism by which CPX inhibits tumor cell proliferation.
- To investigate the role of Cdc25A protein in CPX-mediated anticancer activity.
Main Methods:
- Assessing CPX's impact on Cdc25A protein levels, mRNA, and synthesis in tumor cells.
- Analyzing CPX-induced changes in G1-cyclin dependent kinases (CDKs) phosphorylation.
- Investigating the role of Cdc25A phosphorylation at specific sites (S76 and S82) in CPX sensitivity using mutants.
- Evaluating the effect of Cdc25A-S82A mutant expression on CPX-induced cell proliferation inhibition.
Main Results:
- CPX significantly reduces Cdc25A protein levels without affecting its mRNA or synthesis, indicating promotion of protein degradation.
- CPX treatment leads to increased inhibitory phosphorylation of G1-CDKs.
- CPX enhances Cdc25A phosphorylation at S76 and S82 residues.
- A Cdc25A-S82A mutant exhibits resistance to CPX-induced degradation, and its ectopic expression partially confers resistance to CPX's antiproliferative effects.
Conclusions:
- CPX inhibits tumor cell proliferation, at least partially, by inducing Cdc25A protein degradation.
- The phosphorylation of Cdc25A at S82 is critical for CPX-induced degradation and subsequent inhibition of cell proliferation.
More Related Videos
12:02Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
Published on: June 6, 2017
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
Related Concept Videos
Inhibition of Cdk Activity
Negative Regulator Molecules
Positive Regulator Molecules
Abnormal Proliferation
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Anaphase Promoting Complex